Jackson Grant Investment Advisers’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.05K | Hold |
122
| – | – | ﹤0.01% | 365 |
|
|
2025
Q1 | $1.88K | Hold |
122
| – | – | ﹤0.01% | 363 |
|
|
2024
Q4 | $2.69K | Hold |
122
| – | – | ﹤0.01% | 360 |
|
|
2024
Q3 | $2.2K | Hold |
122
| – | – | ﹤0.01% | 374 |
|
|
2024
Q2 | $1.98K | Hold |
122
| – | – | ﹤0.01% | 372 |
|
|
2024
Q1 | $1.72K | Hold |
122
| – | – | ﹤0.01% | 368 |
|
|
2023
Q4 | $1.27K | Hold |
122
| – | – | ﹤0.01% | 376 |
|
|
2023
Q3 | $1.24K | Hold |
122
| – | – | ﹤0.01% | 376 |
|
|
2023
Q2 | $919 | Hold |
122
| – | – | ﹤0.01% | 409 |
|
|
2023
Q1 | $1.08K | Hold |
122
| – | – | ﹤0.01% | 440 |
|
|
2022
Q4 | $1.11K | Hold |
122
| – | – | ﹤0.01% | 314 |
|
|
2022
Q3 | $1K | Hold |
122
| – | – | ﹤0.01% | 345 |
|
|
2022
Q2 | $1K | Buy |
+122
| New | +$1K | ﹤0.01% | 352 |
|
|
2016
Q1 | – | Sell |
-200
| Closed | -$13K | – | 196 |
|
|
2015
Q4 | $13K | Buy |
+200
| New | +$13K | 0.01% | 159 |
|